Evidence map›Paper›PMID 19282377›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2009

Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways.

Kara Gross, Iordanes Karagiannides, Thomas Thomou, Hon Wai Koon, Collin Bowe, Ho Kim, Nino Giorgadze, Tamara Tchkonia, Tamara Pirtskhalava, James L Kirkland and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. MiR-21 in Substance P-induced exosomes promotes cell proliferation and migration in human colonic epithelial cells.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Role of G protein-coupled receptors-microRNA interactions in gastrointestinal pathophysiology.American journal of physiology. Gastrointestinal and liver physiology · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Lymphatic system: a vital link between metabolic syndrome and inflammation.Annals of the New York Academy of Sciences · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Kara GrossGastrointestinal Neuropeptide Center, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Iordanes Karagiannides
Thomas Thomou
Hon Wai Koon
Collin Bowe
Ho Kim
Nino Giorgadze
Tamara Tchkonia
Tamara Pirtskhalava
James L Kirkland
Charalabos Pothoulakis
Harvard University Press · USMayo Clinic · USBeth Israel Deaconess Medical Center · USGeneral Department of Preventive Medicine · VNUniversity of California, Los Angeles · US

Funding

SUBSTANCE P AND INTESTINAL INFLAMMATIONR01DK047343 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POTHOULAKIS, CHARALABOS · 1994 to 2014
$4.2M
Role of MCH in Adipose Tissue & Intestinal InflammationF32DK076412 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARGOLIS, KARA GROSS · 2006 to 2007
$110k
NIDDK NIH HHS F32-DK076412NIDDK NIH HHS R01-DK47343PHS HHS R01-23960
6 · The paper itself

Abstract

White adipose tissue is intimately involved in the regulation of immunity and inflammation. We reported that human mesenteric preadipocytes express the substance P (SP)-mediated neurokinin-1 receptor (NK-1R), which signals proinflammatory responses. Here we tested the hypothesis that SP promotes proliferation and survival of human mesenteric preadipocytes and investigated responsible mechanism(s). Preadipocytes were isolated from mesenteric fat biopsies during gastric bypass surgery. Proliferative and antiapoptotic responses were delineated in 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), bromodeoxyuridine (BrdU), caspase-3, and TUNEL assays, as well as Western immunoanalysis. SP (10(-7) M) increased MTS and proliferation (BrdU) and time dependently (15-30 min) induced Akt, EGF receptor, IGF receptor, integrin alphaVbeta3, phosphatidylinositol 3-kinase, and PKC-theta phosphorylation. Furthermore, pharmacological antagonism of Akt and PKC-theta activation significantly attenuated SP-induced preadipocyte proliferation. Exposure of preadipocytes to the proapoptotic Fas ligand (FasL, 100 microM) resulted in nuclear DNA fragmentation (TUNEL assay), as well as increased cleaved poly (ADP-ribose) polymerase, cleaved caspase-7, and caspase-3 expression. Cotreatment with SP almost completely abolished these responses in a NK-1R-dependent fashion. SP (10(-7) M) also time dependently stimulated expression 4E binding protein 1 and phosphorylation of p70 S6 kinase, which increased protein translation efficiency. SP increases preadipocyte viability, reduces apoptosis, and stimulates proliferation, possibly via cell cycle upregulation and increased protein translation efficiency. SP-induced proliferative and antiapoptotic pathways in fat depots may contribute to development of the creeping fat and inflammation characteristic of Crohn's disease.

Indexed as

ApoptosisCell ProliferationSignal TransductionAdaptor Proteins, Signal TransducingAdipocytesCaspase 3Caspase 7Cell CycleCell Cycle ProteinsCells, CulturedCell SurvivalErbB ReceptorsFas Ligand ProteinHumansIntegrin alphaVbeta3Intra-Abdominal FatAdaptor Proteins, Signal TransducingCASP3 protein, humanCASP7 protein, humanCaspase 3Caspase 7Cell Cycle ProteinsEGFR protein, humanEIF4EBP1 protein, humanErbB ReceptorsFas Ligand ProteinIntegrin alphaVbeta3IsoenzymesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPhosphoproteinsPoly(ADP-ribose) PolymerasesPRKCQ protein, humanProtein Kinase CProtein Kinase C-thetaProtein Kinase InhibitorsProto-Oncogene Proteins c-aktReceptor, IGF Type 1Receptors, Neurokinin-1Ribosomal Protein S6 Kinases, 70-kDaSubstance PTumor Necrosis Factor-alpha

Identifiers

PMID19282377
PMCPMC2696212
OpenAlexW2005584939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.